RhizoBriva is a patentedrobust, scalable, highly stable and easily transferable bioreactor-confined bioprocessing technology which demonstrated its potential for both complex recombinant proteins and secondary metabolites production.

Production of molecules of interest:

        - from a single clone cultured for an indefinite period of time,

        - using a fully controlled process enabling a strong  reproducibility  with a constant productivity over time

        - from dedicated "Master Root Banks" / "Working Root Banks" 

        -  using a cost-effective system (low capex & COGS, low initial investment, culture at room temperature, in a very simple medium,                    secretion in the culture medium, enabling a straightforward purification...)

processus simplifie 2.png



+33 (0)322 092 830

  • Blanc LinkedIn Icône